Cargando…
RgIA4 Accelerates Recovery from Paclitaxel-Induced Neuropathic Pain in Rats
Chemotherapeutic drugs are widely utilized in the treatment of human cancers. Painful chemotherapy-induced neuropathy is a common, debilitating, and dose-limiting side effect for which there is currently no effective treatment. Previous studies have demonstrated the potential utility of peptides fro...
Autores principales: | Huynh, Peter N., Giuvelis, Denise, Christensen, Sean, Tucker, Kerry L., McIntosh, J. Michael |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7024385/ https://www.ncbi.nlm.nih.gov/pubmed/31877728 http://dx.doi.org/10.3390/md18010012 |
Ejemplares similares
-
RgIA4 Prevention of Acute Oxaliplatin-Induced Cold Allodynia Requires α9-Containing Nicotinic Acetylcholine Receptors and CD3(+) T-Cells
por: Huynh, Peter N., et al.
Publicado: (2022) -
Cy3-RgIA-5727 Labels and Inhibits α9-Containing nAChRs of Cochlear Hair Cells
por: Fisher, Fernando, et al.
Publicado: (2021) -
Limited Efficacy of α-Conopeptides, Vc1.1 and RgIA, To Inhibit Sensory Neuron Ca(V) Current1,2,3
por: Wright, Andrew B., et al.
Publicado: (2015) -
Crystal Structure of the Monomeric Extracellular Domain of α9 Nicotinic Receptor Subunit in Complex With α-Conotoxin RgIA: Molecular Dynamics Insights Into RgIA Binding to α9α10 Nicotinic Receptors
por: Zouridakis, Marios, et al.
Publicado: (2019) -
RgIA4 Potently Blocks Mouse α9α10 nAChRs and Provides Long Lasting Protection against Oxaliplatin-Induced Cold Allodynia
por: Christensen, Sean B., et al.
Publicado: (2017)